Ask AI
Genetics in pediatric SNHL 1

CE / CME

Optimizing Genetic Evaluation in Pediatric Sensorineural Hearing Loss: A Practical Guide for Hearing Specialists

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Physicians: maximum of 0.50 AMA PRA Category 1 Credit

Nurse Practitioners/Nurses: 0.50 Nursing contact hour

Released: July 30, 2026

Expiration: July 29, 2027

Activity

Progress
1 2 3
Course Completed

Introduction

In this module, John A. Germiller, MD, PhD discusses the latest developments in diagnosing and managing pediatric sensorineural hearing loss (SNHL). Learn how the understanding of genetics linked to pediatric hearing loss has recently evolved, why all children with SNHL need to receive genetic testing and counseling, and how these results and other patient-specific factors inform management planning with current and emerging interventions.

Before continuing with this educational activity, please take a moment to answer the following questions.

How many people with SNHL do you provide care for in a typical week?​

For those who practice in academic or community settings, please indicate your practice setting:

Noah is a 10-month-old boy with bilateral severe to profound SNHL, limited aided benefit with hearing aids, normal cochlear nerves on imaging, and biallelic pathogenic OTOF variants.

Which counseling approach is most appropriate?

You are seeing Sofia, a 14-month-old girl with bilateral severe to profound SNHL and limited benefit with hearing aids. A comprehensive gene panel for hearing loss indicates biallelic pathogenic GJB2 variants. Sofia’s parents ask if they should delay cochlear implant evaluation for Sofia, given the newly approved OTOF-directed gene therapy, and wait for a similar treatment to become available.

Which response is most appropriate?